







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Ray et al. 275 (50): 39727</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Cell%20Signaling%20Technologies&url=http://www.cellsignal.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1011387695.gif" ALT="Smart Antibodies for Cell Signaling Research"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue50/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39727">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M007907200v1">doi:10.1074/jbc.M007907200</A> on September 19, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 50, 39727-39733, December 15, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/50/39727">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/50/39727">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/50/39727">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/50/39727&title=Activation+of+Transcription+Factor+SAF+Involves+Its+Phosphorylation+by+Protein+Kinase+C">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007907200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10995778&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10995778&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Ray+A&link_type=AUTHORSEARCH">Ray, A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Ray+BK&link_type=AUTHORSEARCH">Ray, B. K.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/50/39727&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39727"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/50/39727">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/50/39727<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007907200v1">M007907200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    Activation of Transcription Factor SAF</A> Involves Its
Phosphorylation by Protein Kinase C<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>



<STRONG>
<NOWRAP>
Alpana 
Ray<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>,<WBR>
Alan P. 
Fields<SUP>&#167;</SUP>, and<WBR>
Bimal K. 
Ray<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP><A HREF="#FN154"><SUP>&#182;</SUP></A>
</NOWRAP>
</STRONG>
<P>
From the <SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>&nbsp;Department of Veterinary Pathobiology,
University of Missouri, Columbia, Missouri 65211&nbsp;and the
<SUP>&#167;</SUP>&nbsp;Department of Pharmacology and the Sealy Center for Cancer
Cell Biology, University of Texas Medical Branch,
Galveston, Texas 77555
<P>
Received for publication, August 29,&nbsp;2000, and in revised form, September 18,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<BR CLEAR=ALL><A NAME="Abstract"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>The transcription factor serum amyloid A
(SAA</A>)-activating factor (SAF</A>), a family of zinc finger proteins,
plays a significant<SUP> </SUP>role in the induced expression of the SAA</A> gene.
Activity of SAF</A><SUP> </SUP>is regulated by a phosphorylation event involving
serine/threonine<SUP> </SUP>protein kinase (Ray, A., Schatten, H., and Ray,
B.&nbsp;K.&nbsp;(1999) <I>J.<SUP>&nbsp;</SUP>Biol. Chem.</I> 274,&nbsp;4300-4308; Ray,
A., and Ray, B.&nbsp;K.&nbsp;(1998) <I>Mol.<SUP> </SUP>Cell. Biol.</I> 18,&nbsp;7327-7335). However, the identity of the protein<SUP> </SUP>kinase has so far
remained unknown. Induction of SAA</A> by phorbol<SUP> </SUP>12-myristate
13-acetate, a known agonist of protein kinase C (PKC</A>),<SUP> </SUP>suggested
a potential role of the PKC</A> signaling pathway in the<SUP> </SUP>activation
process. The DNA binding activity of endogenous SAF</A><SUP> </SUP>was increased by
agonists of PKC</A>. <I>In vitro</I> phosphorylation of<SUP> </SUP>SAF-1 by
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> markedly increased its DNA binding ability. Consistent<SUP> </SUP>with
these findings, treatment of cells with activators of PKC</A><SUP> </SUP>or
overexpression of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II in transfected cells increased expression<SUP> </SUP>of an SAF-regulated promoter. Further analysis with a GAL4 reporter<SUP> </SUP>system indicated that PKC-mediated phosphorylation mostly increases<SUP> </SUP>the
DNA binding activity of SAF-1. Together these data indicated<SUP> </SUP>that the
PKC</A> signaling pathway plays a major role in controlling<SUP> </SUP>expression of
SAF-regulated genes by increasing the interaction<SUP> </SUP>between promoter DNA
and phosphorylated SAF</A>.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<BR CLEAR=ALL><A NAME="Introduction"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Serum amyloid A (SAA</A>),<SUP>1</SUP>
an inflammation-responsive gene, is highly induced (100-1000-fold) by
extracellular signals generated<SUP> </SUP>during periods of inflammation (<A HREF="#B1">1</A>, <A HREF="#B2">2</A>).
A higher level of<SUP> </SUP>plasma SAA</A> is linked to the pathophysiology of many
chronic inflammatory<SUP> </SUP>diseases including rheumatoid arthritis and
secondary amyloidosis.<SUP> </SUP>In rheumatoid arthritis and osteoarthritis,
autocrine induction<SUP> </SUP>of collagenase by SAA</A> is shown to be critical for
the destruction<SUP> </SUP>of connective tissues in the affected area (<A HREF="#B3">3-5</A>). SAA</A>
is also<SUP> </SUP>identified as the precursor of amyloid A protein, one of the
chief<SUP> </SUP>constituents of amyloid fibrils found in secondary and
experimental<SUP> </SUP>amyloidosis (<A HREF="#B6">6</A>). Induction of SAA</A> is primarily regulated
via<SUP> </SUP>transcriptional induction of this gene (<A HREF="#B7">7</A>). Several different<SUP> </SUP>cytokines, IL-1, IL-6, and tumor necrosis factor-<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> alone or in<SUP> </SUP>combination, and inflammatory mediators like phorbol 12-myristate<SUP> </SUP>13-acetate (PMA</A>) can increase transcription of the SAA</A> gene (<A HREF="#B2">2</A>,<SUP> </SUP><A HREF="#B6">6</A>, <A HREF="#B8">8</A>).
In addition, corticosteroids have been shown to synergize<SUP> </SUP>the effects
of IL-1 and IL-6 (<A HREF="#B9">9-11</A>). Studies on the mechanism<SUP> </SUP>of SAA</A> gene
induction have shown that activation of SAA</A> in many<SUP> </SUP>tissue types is
regulated by the transcription factor SAF</A> (<A HREF="#B12">12</A>,<SUP> </SUP><A HREF="#B13">13</A>). Many inflammatory
agents that activate SAA</A>, including interleukin-1<SUP> </SUP>and -6,&nbsp;bacterial
lipopolysaccharide, and minimally modified low<SUP> </SUP>density lipoprotein,
also activate SAF</A> and increase its transactivation<SUP> </SUP>potential (<A HREF="#B12">12-16</A>).
These studies also indicated that phosphorylation<SUP> </SUP>of SAF</A>, by a
serine/threonine protein kinase pathway, may be a<SUP> </SUP>critical step in
regulating this process. For insight into mechanisms<SUP> </SUP>by which SAF</A> is
activated and thus regulates expression of SAA</A>,<SUP> </SUP>analysis of its
activation mechanism was<SUP> </SUP>undertaken.
</P>
<P>Induction of SAA</A> by PMA</A>, a known agonist of protein kinase C (PKC</A>),
raises the possibility that a PKC-mediated phosphorylation<SUP> </SUP>event(s) may
play an important role in activating SAF</A>. PKCs play<SUP> </SUP>a crucial role in
regulating many cellular functions including<SUP> </SUP>cell transformation,
growth, and differentiation by modulating<SUP> </SUP>the activity of cellular
target proteins and transcription factors<SUP> </SUP>(for reviews, see Refs.
<A HREF="#B17">17-19</A>). Phosphorylation of many transcription<SUP> </SUP>factors by PKC</A> is a
crucial signal transduction event that results<SUP> </SUP>in an altered expression
pattern of many genes. In the present<SUP> </SUP>study, we show that agonists of
the PKC</A> signaling pathway, including<SUP> </SUP>PMA</A>, can increase expression of an
SAF-dependent promoter as well<SUP> </SUP>as the DNA binding ability
of endogenous SAF</A>. Overexpression of<SUP> </SUP>PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II in transfected cells
without the addition of PKC-inducing<SUP> </SUP>agents produces a similar result.
Taken together, these observations<SUP> </SUP>indicate, for the first time, a role
for activated PKC</A> in modulating<SUP> </SUP>the function of transcription factor
SAF</A> and expression of its<SUP> </SUP>target<SUP> </SUP>genes.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Cell Culture and Transfection--</I>

Rabbit synoviocyte (HIG82)
cells, obtained from the American Type Culture Collection, were derived
from the interarticular<SUP> </SUP>soft tissue of the knee joint of a normal
female New Zealand White<SUP> </SUP>rabbit. These cells maintain many of the
features of normal rabbit<SUP> </SUP>synoviocytes and are activated by phorbol
myristic acid and interleukin-1<SUP> </SUP>(<A HREF="#B20">20</A>). HIG82 cells were cultured in
Dulbecco's modified Eagle's<SUP> </SUP>medium containing high glucose (4.5&nbsp;g/liter) supplemented with<SUP> </SUP>7% fetal calf serum. For induction, HIG82
cells were stimulated<SUP> </SUP>with 100&nbsp;n<font size=-1>M</font> PMA</A>,
4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-phorbol-12,13-didecanoate (4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD),
1-oleoyl-2-acetyl-<I>sn</I>-glycerol<SUP> </SUP>(OAG</A>), and
1,2-dioctanoyl-<I>sn</I>-glycerol (DOG</A>). In some experiments,<SUP> </SUP>different concentrations of PMA</A> and 4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD, as indicated in the<SUP> </SUP>figure legends, were used. Myristoylated protein kinase inhibitor<SUP> </SUP>19-27, a cell-permeable PKC-inhibitory peptide (PKC-I, 19-27),<SUP> </SUP>was
added at concentrations of 10&nbsp;and 50&nbsp;&#181;<font size=-1>M</font> as indicated in
the<SUP> </SUP>figure legends. Calphostin C (<A HREF="#B21">21</A>) and bisindolylmaleimide I<SUP> </SUP>(<A HREF="#B22">22</A>),
specific inhibitors of PKC</A>, were added at a 100&nbsp;n<font size=-1>M</font>
concentration<SUP> </SUP>in the culture medium of HIG82 cells. These agents were
obtained<SUP> </SUP>from<SUP> </SUP>Calbiochem.
<P>
Transient transfections of HIG82 cells were carried out by the calcium
phosphate precipitation method (<A HREF="#B23">23</A>) using a mixture<SUP> </SUP>of plasmid DNAs
containing 1&nbsp;&#181;g of reporter chloramphenicol acetyltransferase<SUP> </SUP>(CAT</A>)
plasmid, 1&nbsp;&#181;g of pSV-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-gal (Promega) as a control for measuring<SUP> </SUP>transfection efficiency, and carrier DNA so that the total amount<SUP> </SUP>of
DNA in each transfection assay remained constant. Forty-eight<SUP> </SUP>hours
after transfection, cells were harvested, and cell extracts<SUP> </SUP>were
prepared by freeze-thaw lysis in 0.25&nbsp;<font size=-1>M</font> Tris-HCl buffer,<SUP> </SUP>pH
8.0.&nbsp;<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-Galactosidase activity was assayed with the substrate<SUP> </SUP><I>o</I>-nitrophenyl-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-<font size=-1>D</font>-galactopyranoside as
described previously (<A HREF="#B23">23</A>).<SUP> </SUP>To normalize for any variation in
transfection efficiency, CAT</A><SUP> </SUP>assays were performed (<A HREF="#B23">23</A>) with cell
extracts containing an<SUP> </SUP>equivalent amount of <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase activity.
Prior to the CAT</A><SUP> </SUP>assay, each cell extract was heated at 60&nbsp;&#176;C for 10&nbsp;min to inactivate<SUP> </SUP>endogenous acetylase activity. Different agents that
were used<SUP> </SUP>in the transfection assay had no effect on <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase
expression.<SUP> </SUP>All transfection experiments were performed at least three<SUP> </SUP>times.



    

    


<P><I>Plasmid Constructs--</I>

The CAT</A> reporter plasmid, wt SAF-CAT was
constructed by ligating three copies of the SAF</A> DNA-binding element,
base pairs <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">254<SUP> </SUP>to <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">226 of the SAA</A> promoter (<A HREF="#B13">13</A>), into the pBLCAT2
plasmid vector<SUP> </SUP>(<A HREF="#B24">24</A>). The sequence of the wild type element was
5'-CCCTTCCTCTCCACCCACAGCCCCC-3'.<SUP> </SUP>A mutant plasmid, mt SAF-CAT, was
constructed by ligating three<SUP> </SUP>copies of the mutated SAF</A> DNA-binding
element into the pBLCAT2<SUP> </SUP>vector. The sequence of mutated
oligonucleotide was
5'-CC<U>A</U>TT<U>A</U>CT<U>G</U>TC<U>G</U>AC<U>TG</U>ACAGC<U>TA</U>CC-3'.<SUP> </SUP>Underlined bases represent altered sequences. SAF</A> expression plasmid<SUP> </SUP>pCMV-SAF1 contained a cDNA encoding SAF1 (<A HREF="#B14">14</A>) subcloned into<SUP> </SUP>the
pcDNA3 (Invitrogen) plasmid. A full-length cDNA encoding the<SUP> </SUP>human PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II gene (<A HREF="#B25">25</A>) cloned in sense orientation into the<SUP> </SUP>pREP
episomal expression vector (Invitrogen) was used for expression<SUP> </SUP>of the
kinase in HIG82<SUP> </SUP>cells.



    

    


<P><I>Oligonucleotides--</I>

The sequences of double-stranded
oligonucleotides synthesized for the use as competitors were as
follows: SAF-wt, 5'-CTTCCTCTCCACCCACAGCCCCC-3';<SUP> </SUP>SAF-mt,
5'-CC<U>A</U>TT<U>A</U>CT<U>G</U>TC<U>G</U>AC<U>TG</U>ACAGC<U>TA</U>CC-3'
(underlined bases represent<SUP> </SUP>altered sequences); Oct-1,
5'-TGTCGAATGCAAATCACTAGAA-3' (Promega<SUP> </SUP>Corp.).



    

    


<P><I>Construction of GAL4-SAF1 Plasmid--</I>

Plasmid RSV-GAL4DBD (<A HREF="#B26">26</A>),
encoding the DNA-binding domain of GAL4 driven by the RSV</A> promoter and
followed by a <I>Bam</I>HI site<SUP> </SUP>was used to prepare the GAL4-SAF1
construct. A full-length SAF-1<SUP> </SUP>cDNA was fused in frame C-terminal
to GAL4 amino acids 1-147 at<SUP> </SUP>the <I>Bam</I>HI site. The resulting
RSVGAL4DBD-SAF1 clone contained<SUP> </SUP>two synthetic amino acids at the
junction and was verified by<SUP> </SUP>DNA sequencing. To assay activation, a
reporter CAT</A> gene with<SUP> </SUP>minimum basal activity and three GAL4-binding
sites, pGAL4-CAT<SUP> </SUP>(<A HREF="#B26">26</A>), was<SUP> </SUP>chosen.



    

    


<P><I>Bacterial Expression of SAF-1 (FLAG-SAF1)--</I>

A cDNA
encoding full-length SAF1 sequence was subcloned into pAR(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">RI)59/60
(<A HREF="#B27">27</A>), a FLAG-tagged vector kindly provided by<SUP> </SUP>Dr. Michael Blanar.
<I>Escherichia coli</I> BL21(DE3/pLysS) cells transformed<SUP> </SUP>with this
plasmid were grown to an optical density of 0.6&nbsp;(<I>A</I><SUB>600</SUB>),<SUP> </SUP>and expression of FLAG-SAF1 protein was
induced with 1.0&nbsp;m<font size=-1>M</font>
isopropyl-1-thio-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-<font size=-1>D</font>-galactopyranoside<SUP> </SUP>for 3&nbsp;h.
FLAG-SAF1 protein was purified by affinity chromatography<SUP> </SUP>on
anti-FLAG-agarose (Sigma) following the manufacturer's<SUP> </SUP>protocol.



    

    


<P><I>Nuclear Extracts and Electromobility Shift Assay
(EMSA</A>)--</I>

Nuclear extracts were prepared, following a method
described earlier (<A HREF="#B13">13</A>), from HIG82 cells that were treated with various<SUP> </SUP>agents as described throughout. EMSA</A> was performed with equal<SUP> </SUP>protein
amounts of nuclear extracts according to the methods described<SUP> </SUP>previously (<A HREF="#B14">14</A>). Protein concentrations were measured by following<SUP> </SUP>Bradford's method (<A HREF="#B28">28</A>). Bacterially expressed FLAG-SAF1 was<SUP> </SUP>used in
some EMSAs as the source of DNA-binding factor. For antibody<SUP> </SUP>interaction studies, anti-SAF1 antiserum (<A HREF="#B14">14</A>) and anti-FLAG<SUP> </SUP>antiserum
(Sigma) were added to the reaction mixture during a<SUP> </SUP>preincubation period of 30&nbsp;min on ice. Radiolabeled probes, SAF</A><SUP> </SUP>and
Oct-1, were prepared by incorporating <SUP>32</SUP>P at the termini of
double-stranded oligonucleotides whose sequences<SUP> </SUP>are described under
"Oligonucleotides."



    

    


<P><I>In Vitro Phosphorylation of SAF1 by PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">--</I>

Bacterially
expressed and affinity-purified FLAG-SAF1 protein was phosphorylated
<I>in vitro</I> by incubating 0.1&nbsp;&#181;g of SAF1 protein<SUP> </SUP>with 1.0&nbsp;unit of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (Upstate Biotechnology, Inc., Lake Placid,<SUP> </SUP>NY) in a
buffer system containing 10&nbsp;m<font size=-1>M</font> HEPES, pH 7.9,&nbsp;10&nbsp;m<font size=-1>M</font> MgCl<SUB>2</SUB>,<SUP> </SUP>0.1&nbsp;m<font size=-1>M</font> EDTA, 1&nbsp;m<font size=-1>M</font> dithiothreitol, 0.1&nbsp;m<font size=-1>M</font> ZnCl<SUB>2</SUB>,
0.2&nbsp;m<font size=-1>M</font> sodium<SUP> </SUP>orthovanadate, 5&nbsp;m<font size=-1>M</font> NaF, 1&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl fluoride, 0.5<SUP>&nbsp;</SUP>mg/ml benzamidine, 10&nbsp;&#181;Ci of [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP in a 20-&#181;l reaction mixture for
45&nbsp;min at 25&nbsp;&#176;C. Immunoprecipitation<SUP> </SUP>of phosphorylated proteins was
conducted by incubating with an<SUP> </SUP>anti-FLAG antibody (Sigma) at 4&nbsp;&#176;C
for 14-16 h in the immunoprecipitation<SUP> </SUP>buffer, containing 50&nbsp;m<font size=-1>M</font> Tris-HCl, pH 8.0,&nbsp;150&nbsp;m<font size=-1>M</font> NaCl, 1% (v/v)<SUP> </SUP>Nonidet P-40, 0.1% (w/v) SDS, 2.5&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl
fluoride,<SUP> </SUP>0.5&nbsp;mg/ml benzamidine. Next, 50&nbsp;&#181;l of protein G-agarose
slurry<SUP> </SUP>was added to the reaction mixture and incubated for 2&nbsp;h at
4&nbsp;&#176;C<SUP> </SUP>with gentle shaking in a rotary shaker. After centrifugation,<SUP> </SUP>the pellet was washed five times with the immunoprecipitation<SUP> </SUP>buffer (5&nbsp;min each) to remove any unbound radioactivity. The pellet<SUP> </SUP>was
resuspended in 20&nbsp;&#181;l of buffer containing 2% SDS, 50&nbsp;m<font size=-1>M</font>
Tris-HCl,<SUP> </SUP>pH 6.8,&nbsp;5% <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-mercaptoethanol and heated at 100&nbsp;&#176;C for
10&nbsp;min.<SUP> </SUP>These mixtures were fractionated in an SDS-11% polyacrylamide<SUP> </SUP>gel, and phosphorylated proteins were detected by<SUP> </SUP>autoradiography.
<P>
For use in DNA-binding assays, purified FLAG-SAF1 protein was incubated
with 1.0&nbsp;unit of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (Upstate Biotechnology) in<SUP> </SUP>a buffer system
containing 10&nbsp;m<font size=-1>M</font> HEPES, pH 7.9,&nbsp;60&nbsp;m<font size=-1>M</font> KCl, 5&nbsp;m<font size=-1>M</font><SUP> </SUP>MgCl<SUB>2</SUB>, 0.1&nbsp;m<font size=-1>M</font> EDTA, 1&nbsp;m<font size=-1>M</font> dithiothreitol, 0.1&nbsp;m<font size=-1>M</font> ZnCl<SUB>2</SUB>,
0.5% (v/v)<SUP> </SUP>Nonidet P-40, 10% (v/v) glycerol, 50&nbsp;&#181;g/ml poly(dI-dC),
0.2&nbsp;m<font size=-1>M</font><SUP> </SUP>sodium orthovanadate, 5&nbsp;m<font size=-1>M</font> NaF, 1&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl fluoride,<SUP> </SUP>0.5&nbsp;mg/ml benzamidine,
and 1&nbsp;m<font size=-1>M</font> ATP in a 10-&#181;l reaction mixture.<SUP> </SUP>Phosphorylated
SAF-1 protein was further incubated with a radioactive<SUP> </SUP>SAF</A> DNA-binding
element and electrophoresed in a 6% native polyacrylamide<SUP> </SUP>gel. In some
reactions, FLAG-SAF1 protein was preincubated with<SUP> </SUP>1&nbsp;&#181;<font size=-1>M</font>
of PKC</A> 19-31 inhibitor peptide (Calbiochem) prior to the<SUP> </SUP>addition of
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. Dephosphorylation of FLAG-SAF1 protein was<SUP> </SUP>conducted by
including 4&nbsp;units of calf intestinal alkaline phosphatase<SUP> </SUP>during
<I>in vitro</I> phosphorylation of FLAG-SAF1 protein. As a control,<SUP> </SUP>some reaction mixtures contained, in addition to calf intestinal<SUP> </SUP>alkaline phosphatase, an additional amount of phosphatase inhibitors<SUP> </SUP>(50&nbsp;m<font size=-1>M</font> NaF, 1&nbsp;m<font size=-1>M</font> sodium orthovanadate, and 5&nbsp;&#181;<font size=-1>M</font> okadaic acid).<SUP> </SUP>For antibody interaction studies in
EMSA</A>, FLAG-SAF1 protein was<SUP> </SUP>incubated with anti-FLAG and anti-SAF
antibodies (1.5&nbsp;&#181;l of undiluted<SUP> </SUP>stock) for 30&nbsp;min on ice prior to the
addition of PKC</A> enzyme or<SUP> </SUP>the radioactive<SUP> </SUP>probe.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Induction of SAA</A> mRNA by PMA</A> in HIG82 Synoviocyte
Cells--</I>

PMA</A> is involved in many cellular processes including
growth, differentiation, and development (reviewed in Refs. <A HREF="#B29">29-32</A>).
These<SUP> </SUP>biological potentials of PMA</A> are realized by its ability to
activate<SUP> </SUP>multiple protein kinase cascades facilitating many cellular
events.<SUP> </SUP>The underlying mechanism of these cellular events is the
regulation<SUP> </SUP>of many transcription factors via phosphorylation triggered
by<SUP> </SUP>PMA-stimulated protein kinases. The consequence of this action<SUP> </SUP>is
the induction of expression of genes responsive to these transcription<SUP> </SUP>factors. SAA</A> is one such gene shown to be activated by PMA</A> (<A HREF="#B3">3-5</A>,<SUP> </SUP><A HREF="#B33">33</A>).
To determine whether PMA</A> treatment cause induction of SAA</A><SUP> </SUP>in rabbit
synoviocyte HIG82 cells (ATCC) under the present culturing<SUP> </SUP>condition,
HIG82 cells were cultured with PMA</A> (100&nbsp;n<font size=-1>M</font>) for 24<SUP>&nbsp;</SUP>h,
and the level of SAA</A> mRNA was measured by Northern blot analysis<SUP> </SUP>(Fig. <a href="#F1">1</a>). PMA</A> treatment caused marked
induction of SAA</A> mRNA level<SUP> </SUP>(compare <I>lanes 1</I>&nbsp;and <I>2</I>). The same blot was probed with an actin<SUP> </SUP>cDNA to
measure the quantity and quality of input mRNA. These<SUP> </SUP>results
showed that under our culturing condition, in HIG82 synoviocyte<SUP> </SUP>cells,
the SAA</A> gene is induced by PMA</A>. Since PMA</A> is a known agonist<SUP> </SUP>of protein
kinase C, these data suggested the possibility of the<SUP> </SUP>involvement of
PKC</A> in SAA</A> gene induction. Previous studies showed<SUP> </SUP>that induction of
SAA</A> in nonhepatic cells, including synoviocyte<SUP> </SUP>cells, is primarily
regulated by the SAF</A> transcription factor<SUP> </SUP>(<A HREF="#B12">12-14</A>). We therefore
investigated whether SAF</A> is involved in the<SUP> </SUP>regulation of SAA</A> induction
in response to PMA</A> treatment.



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=80 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4809311001.gif"></A><BR>

<STRONG>View larger version</STRONG> (32K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F1"
onClick="startTarget('F1', 326, 640); this.href='/cgi/content-nw/full/275/50/39727/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Induction of </B><B>SAA</B></A><B> mRNA by </B><B>PMA</B></A>. Rabbit
synoviocyte HIG82 cells were grown in the presence of PMA</A> (100&nbsp;n<font size=-1>M</font>) for 24&nbsp;h. Total RNA was prepared, and equal
amounts (50&nbsp;&#181;g) were fractionated in formaldehyde-agarose gel,
transferred to a nylon membrane, and hybridized to SAA</A> cDNA probe
(<I>top panel</I>). <I>Lane 1</I>, RNA
prepared from untreated cells; <I>lane 2</I>, RNA
prepared from PMA-treated cells. For quantitative and qualitative
evaluation, the membrane was reprobed with actin cDNA
(<I>bottom panel</I>).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->







    

    


<P><I>Increase of DNA Binding Activity in PMA-stimulated
Cells--</I>

HIG82 cells were incubated in the presence of various
concentrations of PMA</A> for 30&nbsp;min. Nuclear extracts prepared from these<SUP> </SUP>PMA-treated cells were subjected to a DNA-binding assay using<SUP> </SUP>a
radiolabeled SAF</A> DNA-binding element of the SAA</A> promoter (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">254<SUP> </SUP>to
<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">226) as the probe. While untreated cell nuclear extract (Fig.<SUP> </SUP><a href="#F2">2</a><I>A</I>, <I>lane
1</I>) formed several DNA-protein complexes (<I>c-e</I>),
PMA</A> treatment<SUP> </SUP>(Fig. <a href="#F2">2</a><I>A</I>, <I>lanes 2-4</I>),
led to the appearance of some additional<SUP> </SUP>complexes (<I>a</I> and
<I>b</I>) in a concentrationdependent manner. At a higher<SUP> </SUP>concentration of PMA</A> (<I>lane 4</I>), the levels of
complexes <I>c</I> and <I>d</I><SUP> </SUP>were also increased. These
results indicated induction of some<SUP> </SUP>nuclear proteins by PMA</A> that can
interact with the SAF</A> DNA-binding<SUP> </SUP>element. To determine if induction of
DNA binding activity is<SUP> </SUP>specific to PMA</A> action, HIG82 cells were
treated with inactive<SUP> </SUP>phorbol ester 4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD. In contrast to PMA</A>, there
was no change<SUP> </SUP>in the DNA binding activity in 4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD-treated cells
(Fig. <a href="#F2">2</a><I>A</I>,<SUP> </SUP><I>lanes 5-7</I>). Next, we
determined the kinetics of induction of DNA-protein<SUP> </SUP>complexes by
treating HIG82 cells with 100&nbsp;n<font size=-1>M</font> PMA</A> for different<SUP> </SUP>lengths
of time. Time course studies showed that PMA</A> treatment<SUP> </SUP>causes a rapid
induction, within 30&nbsp;min, of several complexes<SUP> </SUP>including <I>a</I>,
<I>b</I>, and <I>c</I> (Fig. <a href="#F2">2</a><I>B</I>, <I>lanes
1-4</I>). However, the intensity<SUP> </SUP>of these inducible complexes
declined considerably at the 90-min<SUP> </SUP>time point (<I>lane
4</I>). Prolonged incubation, up to 24&nbsp;h (data not<SUP> </SUP>shown)
exhibited a pattern similar to the level seen at the 90-min<SUP> </SUP>time point.
These results indicated that PMA</A> rapidly induces activities<SUP> </SUP>of some
nuclear protein that can interact with the SAF</A> DNA-binding<SUP> </SUP>element. The
specificity of PMA</A> action was verified by monitoring<SUP> </SUP>the DNA binding
activity of an unrelated transcription factor.<SUP> </SUP>Oct-1 DNA binding
activity was assayed in various PMA-treated<SUP> </SUP>cells. Members of the Oct
family of transcription factors specifically<SUP> </SUP>interact with an octamer
motif, ATGCAAAT, a regulatory element<SUP> </SUP>important for tissue- and
cell-specific transcription as well<SUP> </SUP>as for transcription of many
housekeeping genes (<A HREF="#B34">34</A>). No significant<SUP> </SUP>change in the level of Oct-1
DNA binding activity was noted in<SUP> </SUP>these PMA-treated cells (Fig.
<a href="#F2">2</a><I>C</I>, <I>lanes 1-4</I>). The kinetics of<SUP> </SUP>PMA</A>
action on these nuclear proteins is consistent with the mode<SUP> </SUP>of action
of PMA</A> in many other cell types. The accumulation of<SUP> </SUP>SAA</A> mRNA
begins early, but build up of a considerable pool of<SUP> </SUP>the mRNA that
can be detected by Northern analysis employed in<SUP> </SUP>the present study
(Fig. <a href="#F1">1</a>) takes at least several hours of treatment,<SUP> </SUP>and a large amount
of accumulated SAA</A> mRNA was detected at 24<SUP>&nbsp;</SUP>h of treatment.



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=99 SRC="/content/vol275/issue50/images/small/bc4809311002.gif"></A><BR>

<STRONG>View larger version</STRONG> (58K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F2"
onClick="startTarget('F2', 590, 418); this.href='/cgi/content-nw/full/275/50/39727/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>PMA</B></A><B> treatment causes activation of some
nuclear proteins that bind to the </B><B>SAF</B></A><B> DNA-binding element of </B><B>SAA</B></A><B>
promoter.</B> <I>A</I>, HIG82 cells were incubated in the presence
of various concentrations (as indicated) of PMA</A> (<I>lanes
2-4</I>) and 4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD (<I>lanes 5-7</I>) for 30&nbsp;min. Nuclear extracts (10&nbsp;&#181;g of protein) prepared from these cells
were incubated with a <SUP>32</SUP>P-labeled SAF</A> DNA-binding element
(<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">254/<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">226) present in the SAA</A> promoter. The reaction mixtures were
fractionated in a native 6% polyacrylamide gel. <I>Lane
1</I>, equal amount of nuclear extract (10&nbsp;&#181;g of protein)
prepared from untreated cells. <I>B</I>, HIG82 cells were incubated
in the presence of 100&nbsp;n<font size=-1>M</font> PMA</A> for various lengths of time
(as indicated in the <I>figure</I>). Nuclear extracts (10&nbsp;&#181;g)
prepared from these cells were subjected to a DNA-binding assay with
radiolabeled SAF</A> DNA-binding element described above. Different
DNA-protein complexes are designated as complexes <I>a-e.
C</I>, nuclear extracts (10&nbsp;&#181;g) prepared from various
PMA-treated cells (<I>lanes 1-4</I>) as used in
<I>B</I> were subjected to a DNA-binding assay with a radiolabeled
Oct-1 DNA-binding element as the probe. The Oct1-DNA complex is
designated as Oct1.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->







    

    


<P><I>Characterization of the DNA-Protein Complexes--</I>

PMA-induced
DNA-protein complexes were characterized by using wild type SAF</A>
DNA-binding oligonucleotide, nonspecific unrelated<SUP> </SUP>oligonucleotide, and a mutant SAF</A> DNA-binding oligonucleotide<SUP> </SUP>(Fig. <a href="#F3">3</a><I>A</I>, <I>lanes
1-5</I>). Competition with the molar excess of homologous<SUP> </SUP>SAF</A>
oligonucleotide inhibited all complexes but the complex <I>c</I><SUP> </SUP>(<I>lanes 2</I>&nbsp;and <I>3</I>). No change in the
DNA-protein complex formation<SUP> </SUP>was observed during competition with
mutant SAF</A> DNA-binding oligonucleotide<SUP> </SUP>(<I>lane 4</I>)
or an unrelated nonspecific oligonucleotide (<I>lane
5</I>).<SUP> </SUP>An anti-SAF antibody (Fig. <a href="#F3">3</a><I>B</I>,
<I>lanes 2</I>&nbsp;and <I>3</I>) inhibited all complexes<SUP> </SUP>except the complex <I>c</I>. The anti-SAF antibody interacts with
the<SUP> </SUP>zinc finger domain of the SAF</A> family of proteins and thereby can<SUP> </SUP>neutralize multiple members of this family. From these results,<SUP> </SUP>we
conclude that complexes <I>a</I>, <I>b</I>, <I>d</I>, and
<I>e</I> are formed by SAF-related<SUP> </SUP>proteins. The identity of
complex <I>c</I>, which is also slightly induced<SUP> </SUP>by PMA</A>, presently
is not very clear. Since complex <I>c</I> was not inhibited<SUP> </SUP>by a
molar excess of competing homologous probe (Fig. <a href="#F3">3</a><I>A</I>,
<I>lanes<SUP> </SUP>2</I>&nbsp;and <I>3</I>), we believe that this
complex is formed by a nuclear<SUP> </SUP>factor unrelated to SAF</A> and has a very
low affinity toward the<SUP> </SUP>SAF</A> DNA-binding element. Furthermore, when
SAF-specific DNA binding<SUP> </SUP>was completely inhibited by the addition of
higher levels of SAF</A><SUP> </SUP>antibody, there was a slight increase in the
binding of this unrelated<SUP> </SUP>factor, which increased the level of complex
<I>c</I> (Fig. <a href="#F3">3</a><I>B</I>, <I>lane<SUP> </SUP>3</I>). Taken
together, these results showed that treatment of cells<SUP> </SUP>with PMA</A> causes
induction of some SAF-like DNA binding activity<SUP> </SUP>in HIG82 synovial
cells.



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=195 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4809311003.gif"></A><BR>

<STRONG>View larger version</STRONG> (74K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F3"
onClick="startTarget('F3', 578, 640); this.href='/cgi/content-nw/full/275/50/39727/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Characterization of DNA-protein
complexes.</B> <I>A</I>, nuclear extracts (10&nbsp;&#181;g) prepared from
HIG82 cells treated with 100&nbsp;n<font size=-1>M</font> of PMA</A> for 30&nbsp;min were
subjected to a DNA-binding assay with radiolabeled SAF</A> DNA-binding
element (<I>lanes 1-5</I>). <I>Lane
2</I>, 50-fold molar excess of double-stranded wild type
(<I>wt</I>) SAF</A> DNA-binding oligonucleotide; <I>lane
3</I>, 100-fold molar excess of wild type SAF</A> DNA-binding
oligonucleotide; <I>lane 4</I>, 100-fold molar excess of
mutant (<I>mt</I>) SAF</A> DNA-binding element; <I>lane
5</I>, 100-fold molar excess of an unrelated (<I>ur</I>)
oligonucleotide, Oct-1. <I>B</I>, nuclear extracts (10&nbsp;&#181;g)
prepared from HIG82 cells treated with 100&nbsp;n<font size=-1>M</font> PMA</A> for 30&nbsp;min were subjected to a DNA-binding assay with the radiolabeled SAF</A>
DNA-binding element described above. In addition to nuclear extract,
<I>lanes 2</I>&nbsp;and <I>3</I>&nbsp;contain 1&nbsp;and 2&nbsp;&#181;l of
anti-SAF antibody, respectively, and <I>lane 4</I>&nbsp;contains 2&nbsp;&#181;l of preimmune serum. Different DNA-protein complexes are
designated as complexes <I>a-e</I>.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->







    

    


<P><I>Regulators of Protein Kinase C Induce SAF</A> Activity--</I>

Since PMA</A>
is a potent activator of the PKC</A> signaling pathway, we investigated
whether PKC</A> acts as a physiological regulator<SUP> </SUP>of SAF</A>. If during PMA</A>
treatment SAF</A> was activated by PKC</A>, then<SUP> </SUP>other cellular activators of
PKC</A> should also activate SAF</A>. OAG</A><SUP> </SUP>and DOG</A> are known as potent
stimulators of cellular PKC</A> activity.<SUP> </SUP>As shown in Fig.
<a href="#F4">4</a><I>A</I>, like PMA</A>, both OAG</A> and DOG</A>
stimulated the<SUP> </SUP>DNA binding ability of SAF</A> (<I>lanes
2</I>&nbsp;and <I>3</I>). Calphostin C is a<SUP> </SUP>highly specific
inhibitor of PKC</A> (<A HREF="#B21">21</A>), which interacts with<SUP> </SUP>the protein's regulatory
domain by competing at the binding site<SUP> </SUP>of diacylglycerol and phorbol
esters. Calphostin C inhibited the<SUP> </SUP>PMA-mediated increase of SAF</A> DNA
binding activity (<I>lane 4</I>). A<SUP> </SUP>similar result
(<I>lane 5</I>) was obtained with a more specific,
cell-permeable<SUP> </SUP>PKC</A> inhibitor peptide 19-27 that inhibits PKC</A> function
by acting<SUP> </SUP>as a pseudosubstrate. From these findings, we conclude that
PKC</A><SUP> </SUP>may be involved in a major way in the PMA-induced activation of<SUP> </SUP>SAF</A>, which subsequently increases SAA</A> expression.



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=130 SRC="/content/vol275/issue50/images/small/bc4809311004.gif"></A><BR>

<STRONG>View larger version</STRONG> (40K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F4"
onClick="startTarget('F4', 590, 485); this.href='/cgi/content-nw/full/275/50/39727/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>Inducers of </B><B>PKC</B></A><B> can increase </B><B>SAF</B></A><B> DNA binding
activity and expression of a SAF-regulated promoter.</B> <I>A</I>,
HIG82 cells were incubated for 30&nbsp;min in the presence of various
activators and inhibitors of PKC</A> activity. Nuclear extracts (10&nbsp;&#181;g)
prepared from these cells were subjected to a DNA-binding assay with a
<SUP>32</SUP>P-labeled SAF</A> DNA-binding element (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">254/<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">226) of the
SAA</A> promoter. <I>Lane 1</I>, untreated cells;
<I>lanes 2-4</I>, cells treated with OAG</A>, DOG</A>, and PMA</A>
plus calphostin C, respectively. <I>Lane 5</I>, PMA</A> plus
cell-permeable inhibitor peptide (PKC-I 19-27)-treated cells.
<I>Lane 6</I>, PMA-treated cells. PMA</A>, OAG</A>, DOG</A>, and
calphostin C were added at 100&nbsp;n<font size=-1>M</font>, and PKC-I 19-27 was
added at 50&nbsp;&#181;<font size=-1>M</font>. <I>B</I>, HIG82 cells were
transfected with 1.0&nbsp;&#181;g of either wild type (<I>wt</I>) or mutant
(<I>mt</I>) SAF-CAT reporter construct. In some transfection assay
mixture, SAF1 expression plasmid, pCMV-SAF1 (1.0&nbsp;&#181;g), was included.
Following transfection, cells were incubated with either PMA</A>, OAG</A>,
calphostin C, or bisindolylmaleimide I.&nbsp;These PKC</A> regulators were added
at 100&nbsp;n<font size=-1>M</font> concentrations of each. The CAT</A> assay was
performed as described under "Experimental Procedures." Results
represent averages of three separate experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->




<P>
We next asked whether inducers of PKC</A> increase functional activity of
SAF</A>. To test this possibility, HIG82 cells were cotransfected<SUP> </SUP>with a
reporter gene (SAF-CAT), containing three copies of SAF</A><SUP> </SUP>DNA-binding
elements present in the SAA</A> promoter, and an expression<SUP> </SUP>vector
containing a full-length cDNA of SAF1. The cells cotransfected<SUP> </SUP>with
the reporter plasmid and pCMV-SAF1 exhibited an approximately<SUP> </SUP>4-fold
higher level of CAT</A> activity than cells transfected with<SUP> </SUP>the reporter
gene itself (Fig. <a href="#F4">4</a><I>B</I>). However, the transactivating<SUP> </SUP>potential of pCMV-SAF1 was markedly higher in the presence of<SUP> </SUP>agonists
of PKC</A>, such as PMA</A> or OAG</A>, and substantially lower in<SUP> </SUP>the presence of
inhibitors of PKC</A>, namely bisindolylmaleimide<SUP> </SUP>I (<A HREF="#B22">22</A>) or calphostin C
(<A HREF="#B21">21</A>). The increase of reporter gene<SUP> </SUP>expression by pCMV-SAF1 in the
absence of any agonists of PKC</A>,<SUP> </SUP>we believe, is due to the activation of
SAF1 by low basal levels<SUP> </SUP>of endogenous active PKCs that are present in
the transfected<SUP> </SUP>cells. The specificity of pCMV-SAF1-mediated
transactivation was<SUP> </SUP>verified by using a mutant reporter gene that
contained three<SUP> </SUP>copies of mutated SAF</A> DNA-binding elements. The mutant
reporter<SUP> </SUP>did not respond to any of these agents. Together, these data
indicate<SUP> </SUP>that agonists of PKC</A> increase the expression of SAF-regulated<SUP> </SUP>genes in HIG82 synovial<SUP> </SUP>cells.



    

    


<P><I>PKC-mediated Phosphorylation Increases the DNA Binding Activity of
Bacterially Expressed SAF</A> Protein--</I>

In determining the role of PKC</A>
in SAF</A> regulation, we first examined whether PKC</A> can phosphorylate SAF</A>.
A full-length, bacterially<SUP> </SUP>expressed FLAG-SAF1 protein was
affinity-purified over an anti-FLAG<SUP> </SUP>Sepharose column and <I>in
vitro</I> phosphorylated, using purified PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>enzyme (Upstate
Biotechnology) and [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP. Phosphorylated
radioactive SAF</A> was readily detected before<SUP> </SUP>(Fig.
<a href="#F5">5</a><I>A</I>, <I>lane
2</I>) and after immunoprecipitation with anti-FLAG<SUP> </SUP>antibody
(Fig. <a href="#F5">5</a><I>A</I>, <I>lane 4</I>). These results
showed that PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> can<SUP> </SUP>phosphorylate purified FLAG-SAF1 protein.



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=133 SRC="/content/vol275/issue50/images/small/bc4809311005.gif"></A><BR>

<STRONG>View larger version</STRONG> (57K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F5"
onClick="startTarget('F5', 590, 492); this.href='/cgi/content-nw/full/275/50/39727/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B><I>In vitro</I> phosphorylation by
</B><B>PKC</B></A><B>-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> increases the DNA binding activity of
SAF-1.</B> <I>A</I>, purified FLAG-SAF1 protein either alone
(<I>lane 1</I>) or with PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (<I>lanes
2-4</I>) was used in a phosphorylation assay with
[<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP, separated on 11% SDS-polyacrylamide gel
electrophoresis, and autoradiographed. Details of phosphorylation and
immunoprecipitation (<I>IP</I>) reactions are described under
"Experimental Procedures." <I>Lane 1</I>, FLAG-SAF1
protein alone; <I>lane 2</I>, FLAG-SAF1 protein plus
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. Some reaction mixtures were immunoprecipitated with preimmune
serum (<I>lane 3</I>) or with anti-FLAG antibody
(<I>lane 4</I>). Molecular masses of marker
proteins in kilodaltons are indicated. <I>B</I>, phosphorylation of
SAF1 by PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> increases its DNA binding ability. Purified full-length
FLAG-SAF1 protein was subjected to a phosphorylation reaction using
purified PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> enzyme prior to its use in the DNA-binding
assays (<I>lanes 2-5</I>). <I>Lane
1</I>, FLAG-SAF1 protein alone; <I>lanes
2-5</I>, FLAG-SAF1 protein plus 1.0&nbsp;units of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. In
<I>lane 3</I>, 1&nbsp;&#181;<font size=-1>M</font> PKC</A> inhibitor peptide
19-31 was added during phosphorylation of FLAG-SAF1 protein with
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. In <I>lanes 4</I>&nbsp;and <I>5</I>, anti-FLAG
and anti-SAF antibodies were added in the reaction mixture during
phosphorylation of FLAG-SAF1 protein with PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. The <I>arrow</I>
indicates the migration position of supershifted complex in
<I>lane 4.&nbsp;C</I>, purified full-length
FLAG-SAF1 protein was subjected to a phosphorylation reaction using
purified PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> enzyme prior to its use in the DNA-binding
assays as described for <I>B</I> (<I>lanes
2-4</I>). <I>Lane 1</I>, unphosphorylated
FLAG-SAF1 protein. In <I>lanes 3</I>&nbsp;and <I>4</I>,
calf intestinal alkaline phosphatase (<I>CIP</I>) was added during
phosphorylation of FLAG-SAF1 protein. The incubation mixture in
<I>lane 3</I>&nbsp;also contained inhibitors of phosphatase
(NaF (50&nbsp;m<font size=-1>M</font>), okadaic acid (5&nbsp;&#181;<font size=-1>M</font>), and sodium
orthovanadate (1&nbsp;m<font size=-1>M</font>)) during calf intestinal alkaline
phosphatase treatment.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->




<P>
Next, we tested the effect of PKC-mediated phosphorylation on the DNA
binding ability of SAF</A>. Bacterially expressed FLAG-SAF1<SUP> </SUP>protein was
first <I>in vitro</I> phosphorylated with purified PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>enzyme
and nonradioactive ATP and used in a DNA-binding assay.<SUP> </SUP>As seen in Fig.
<a href="#F5">5</a><I>B</I>, untreated FLAG-SAF1 protein interacted poorly<SUP> </SUP>with
radiolabeled SAF</A> DNA-binding element (<I>lane 1</I>),
but upon phosphorylation<SUP> </SUP>with PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, the same protein interacted at a
markedly higher level<SUP> </SUP>(<I>lane 2</I>). Prolonged
exposure of the gel showed a band in <I>lane<SUP> </SUP>1</I>&nbsp;comigrating with the prominent band present in <I>lane
2</I>. No significant<SUP> </SUP>level of binding occurred when an
inhibitor peptide was included<SUP> </SUP>in the phosphorylation reaction mixture
(<I>lane 3</I>). The DNA-protein<SUP> </SUP>complex formed by
PKC-phosphorylated SAF</A> was supershifted by an<SUP> </SUP>anti-FLAG antibody
(<I>lane 4</I>) and inhibited by an anti-SAF antibody<SUP> </SUP>(<I>lane 5</I>). In a reciprocal experiment, we
monitored the effect<SUP> </SUP>of phosphatase and inhibitors of phosphatase on
the DNA binding<SUP> </SUP>activity of <I>in vitro</I> phosphorylated SAF</A>
(Fig. <a href="#F5">5</a><I>C</I>, <I>lanes 1-4</I>).<SUP> </SUP>The addition of
phosphatase severely reduced the DNA binding potential<SUP> </SUP>of <I>in
vitro</I> phosphorylated SAF</A> protein (<I>lane 3</I>),
while phosphatase<SUP> </SUP>inhibitors neutralized the action of phosphatase and
restored<SUP> </SUP>its DNA binding ability (<I>lane 4</I>).
Together, these results demonstrated<SUP> </SUP>that phosphorylation of SAF-1 by
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> is necessary for efficient<SUP> </SUP>DNA binding activity of SAF</A>.



    

    


<P><I>Overexpression of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II Can Enhance Expression of an
SAF-regulated Promoter--</I>

We next asked whether overexpression of
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> in the absence of an inducer of PKC</A> could increase expression
of SAF-regulated<SUP> </SUP>genes. HIG82 cells were cotransfected with the SAF-CAT
reporter<SUP> </SUP>gene and pCMV-SAF1 expression plasmid in the presence or
absence<SUP> </SUP>of a PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II expression plasmid (Fig.
<a href="#F6">6</a>). The addition of increasing<SUP> </SUP>concentrations of expression plasmid carrying PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II in the
transfected<SUP> </SUP>cells increased the transactivation potential of SAF1 in a
dose-dependent<SUP> </SUP>manner. PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II expression was monitored
by Western immunoblot<SUP> </SUP>analysis and found to be higher as the amount of
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II plasmid<SUP> </SUP>DNA was increased (data not shown). The empty vector
had no enhancing<SUP> </SUP>effect, indicating the direct consequence of expressed
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II<SUP> </SUP>in the transfected cells. The addition of the PKC</A> inhibitor
19-27<SUP> </SUP>peptide lowered PKC-stimulated SAF-1 transactivating ability.<SUP> </SUP>


<BR CLEAR=ALL><A NAME="F6"><!-- FIG 6 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F6">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=169 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4809311006.gif"></A><BR>

<STRONG>View larger version</STRONG> (32K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F6">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F6"
onClick="startTarget('F6', 522, 640); this.href='/cgi/content-nw/full/275/50/39727/F6'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F6">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 6. &nbsp;</STRONG>

<B>Overexpression of
</B><B>PKC</B></A><B>-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II increases expression of SAF-regulated
promoters.</B> HIG82 cells were transfected with 1.0&nbsp;&#181;g of SAF-CAT
reporter gene with or without pCMV-SAF1 (1.0&nbsp;&#181;g) plasmid DNA, as
indicated. In some transfection assays, an expression plasmid
containing PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II cDNA was included at amounts of 1,&nbsp;2,&nbsp;and 3&nbsp;&#181;g, respectively. In the <I>last two
lanes</I>, 3&nbsp;&#181;g of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II cDNA was used. As a negative
control, empty vector (3&nbsp;&#181;g) lacking PKC</A> cDNA sequences was used.
Myristoylated PKC</A> inhibitor peptide 19-27 (PKC-I 19-27) was added in
some transfection assays at concentrations of 10&nbsp;and 50&nbsp;&#181;<font size=-1>M</font>, respectively. These results represent an average of
three separate experiments&nbsp;&#177;&nbsp;S.D.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 6 -->







    

    


<P><I>PKC-mediated Phosphorylation Does Not Affect the Transactivation
Potential of SAF--</I>

To define if PKC-mediated phosphorylation
directly affects the transactivating potential of SAF</A>, a full-length
SAF-1 cDNA<SUP> </SUP>was fused in frame to the DNA-binding domain of yeast
transcription<SUP> </SUP>factor GAL4 encoding amino acids 1-147. The resulting
chimera,<SUP> </SUP>RSVGAL4DBD-SAF1, was tested for the its ability to
transactivate<SUP> </SUP>a reporter containing three GAL4 binding sites in front
of a CAT</A><SUP> </SUP>gene. The RSVGAL4DBD-SAF1 construct considerably activated
transcription<SUP> </SUP>of the GAL4-CAT reporter gene (Fig.
<a href="#F7">7</a>, <I>bar B</I>).
Interestingly,<SUP> </SUP>in contrast to results presented in Fig. <a href="#F6">6</a>, the
addition of increasing<SUP> </SUP>concentrations of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II together with a
constant amount of RSVGAL4DBD-SAF1<SUP> </SUP>plasmid displayed virtually no
additional effect on the expression<SUP> </SUP>of GAL4-CAT reporter gene (Fig. <a href="#F7">7</a>,
<I>bars C-E</I>). As a control, we<SUP> </SUP>cotransfected the
cells with GAL4-CAT and pCMVSAF-1 (<I>bar I</I>) or<SUP> </SUP>GAL4-CAT and RSVGAL4DBD (<I>bar A</I>) plasmid DNAs. In
the absence of<SUP> </SUP>a transactivating domain, RSVGAL4DBD plasmid exhibited
very little<SUP> </SUP>stimulating effect on the expression of the GAL4-CAT
reporter<SUP> </SUP>gene. Likewise, in the absence of the GAL4 DNA-binding
domain,<SUP> </SUP>pCMVSAF-1 had no effect on GAL4-CAT reporter gene expression.<SUP> </SUP>These results confirmed that the DNA-binding domains of SAF-1<SUP> </SUP>and yeast
GAL4 protein are different and that activation of GAL4-CAT<SUP> </SUP>reporter
gene by RSVGAL4DBD-SAF1 is due to a combined effect of<SUP> </SUP>the GAL4
DNA-binding domain and the transactivating domain of<SUP> </SUP>SAF-1.
Together, these data show that PKC-mediated phosphorylation<SUP> </SUP>increases
only the DNA-binding potential of SAF-1 and has minimum<SUP> </SUP>effect on
the transactivating domain of this protein.



<BR CLEAR=ALL><A NAME="F7"><!-- FIG 7 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39727/F7">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=174 SRC="/content/vol275/issue50/images/small/bc4809311007.gif"></A><BR>

<STRONG>View larger version</STRONG> (52K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39727/F7">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39727/F7"
onClick="startTarget('F7', 590, 582); this.href='/cgi/content-nw/full/275/50/39727/F7'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F7">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 7. &nbsp;</STRONG>

<B>PKC</B></A><B>-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II does not
alter the activation potential of SAF-1.</B> In the vector RSVGAL4DBD,
GAL4 amino acids 1-147 encoding the DNA-binding domain and nuclear
localization sequence of yeast transcription factor GAL4 are under the
control of the RSV</A> promoter. A full-length SAF-1 cDNA was fused in
frame C-terminal to the DNA-binding domain (at the <I>Bam</I>HI
site) of GAL4 to prepare RSVGAL4DBD-SAF1 plasmid. HIG82 cells were
transiently transfected with 1.0&nbsp;&#181;g of GAL4-CAT reporter DNA, which
contains three copies of the GAL4 binding site. In some transfection
mixtures, as indicated in the <I>figure</I>, RSVGAL4DBD plasmid DNA
(1.0&nbsp;&#181;g) or RSVGAL4DBD-SAF1 DNA (1.0&nbsp;&#181;g) and increasing
amounts (1,&nbsp;2,&nbsp;and 3&nbsp;&#181;g) of an expression plasmid of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II
were used. The results represent an average of three independent
transfection experiments&nbsp;&#177;&nbsp;S.D.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 7 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>In this paper, we have provided direct evidence for the activation
of SAF</A> by the PKC</A> signaling pathway. The following novel<SUP> </SUP>findings were
obtained: (i) agonists of PKC</A> activation pathway<SUP> </SUP>or overexpression of
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II can increase expression of a SAF-regulated<SUP> </SUP>promoter; (ii)
<I>in vitro</I> phosphorylation of bacterially expressed<SUP> </SUP>SAF-1 by
PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> markedly increases its DNA binding ability; and<SUP> </SUP>(iii)
PKC-mediated phosphorylation increases the DNA binding ability<SUP> </SUP>of SAF-1
without affecting its transactivating<SUP> </SUP>potential.
    
    </P>

    
    <P>SAF family of transcription factors was initially identified as a
regulator of the SAA</A> gene, and three members of this family<SUP> </SUP>were
characterized by structural analysis (<A HREF="#B14">14</A>). Multiple DNA-protein<SUP> </SUP>complexes in PMA-treated HIG82 cells that were detected by EMSA</A><SUP> </SUP>(Fig.
<a href="#F2">2</a>) most likely are formed due to homomeric and heteromeric<SUP> </SUP>interaction
of these different SAF</A> isoforms. Among the known SAF</A><SUP> </SUP>family members,
SAF1 has been detected in most cell types, including<SUP> </SUP>HIG82 cells. For
detailed analysis, we have therefore used SAF1<SUP> </SUP>in the present
investigation. The cloned cDNA of SAF1 exhibited<SUP> </SUP>considerable
homology with human MAZ (<A HREF="#B35">35</A>) and mouse Pur-1 (<A HREF="#B36">36</A>)<SUP> </SUP>transcription factor
cDNA, indicating that SAF1 is a member of<SUP> </SUP>this group of
transcription factors. The SAF/MAZ/Pur-1 family<SUP> </SUP>of transcription
factors function as regulators of SAA</A> (<A HREF="#B12">12</A>),<SUP> </SUP>c-<I>myc</I> (<A HREF="#B35">35</A>),
insulin (<A HREF="#B36">36</A>), CD4 (<A HREF="#B37">37</A>), and serotonin 1A receptor<SUP> </SUP>(<A HREF="#B38">38</A>) genes. The
c-<I>myc</I> proto-oncogene is an important factor<SUP> </SUP>in controlling
both cellular proliferation and apoptosis, insulin<SUP> </SUP>is involved in
stimulating cellular metabolism and proliferation,<SUP> </SUP>serotonin 1A
receptor functions as a regulator of neuroendocrine<SUP> </SUP>function, CD4
protein is an important molecule in T-cell development<SUP> </SUP>and activation,
and serum amyloid A is an inflammation-responsive<SUP> </SUP>protein.
Understanding the induction mechanism of the SAF</A> family<SUP> </SUP>of
transcription factors thus has broad biological<SUP> </SUP>implications.
    
    </P>

    
    <P>Protein kinase C family members are known to play important roles in
mediating signal transduction, cellular differentiation,<SUP> </SUP>proliferation,
and apoptosis. The PKC-mediated signaling pathway<SUP> </SUP>also regulates the
inflammatory response mechanism initiated by<SUP> </SUP>many inflammatory agents.
To date, there are at least 12&nbsp;PKC</A> members<SUP> </SUP>(reviewed in Refs. <A HREF="#B17">17-19</A>)
that are classified into three groups:<SUP> </SUP>calcium-dependent or
classic conventional PKC</A> isoforms (<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">I,<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II, <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">);
calcium-independent novel PKC</A> isoforms (<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta ">, <IMG SRC="/math/12pt/normal/epsilon.gif" ALIGN=BASELINE ALT="epsilon ">, <IMG SRC="/math/12pt/normal/eta.gif" ALIGN=BASELINE ALT="eta ">, <IMG SRC="/math/12pt/normal/theta.gif" ALIGN=BASELINE ALT="theta ">);<SUP> </SUP>and
calcium- and diacylglycerol-independent,
phosphatidylserine-dependent<SUP> </SUP>atypical PKC</A> isoforms (<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta ">,
<IMG SRC="/math/12pt/normal/iota.gif" ALIGN=BASELINE ALT="iota ">, <IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda ">, &#181;). It is believed that selected<SUP> </SUP>members may be involved in
mediating diverse cellular responses.<SUP> </SUP>We found that phosphorylation of
SAF-1 protein by PKC</A> markedly<SUP> </SUP>increases its DNA binding activity (Fig.
<a href="#F5">5</a>, <I>B</I> and <I>C</I>). The transactivating<SUP> </SUP>potential of
pCMVSAF-1 in the presence of agonists of PKC</A> (Fig.<SUP> </SUP><a href="#F4">4</a><I>B</I>) or
during overexpression of PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> was also significantly higher<SUP> </SUP>(Fig.
<a href="#F6">6</a>). However, the effect of PKC-mediated phosphorylation<SUP> </SUP>on SAF</A> appears
to be limited to increasing only its DNA binding<SUP> </SUP>activity. A GAL4-SAF1
construct, in which a full-length SAF-1<SUP> </SUP>cDNA is fused in frame to
the C-terminal of the GAL4 DNA-binding<SUP> </SUP>domain, considerably increased
expression of a GAL-CAT reporter<SUP> </SUP>gene, indicating that SAF-1 can confer
transcriptional activation<SUP> </SUP>on a heterologous DNA-binding protein. The
transactivating potential<SUP> </SUP>of GAL4-SAF1 was not altered when transfected
cells were allowed<SUP> </SUP>to overexpress PKC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> protein (Fig. <a href="#F7">7</a>). These
results suggested<SUP> </SUP>that PKC-mediated phosphorylation has little effect
on the transactivating<SUP> </SUP>domains of SAF-1.
    
    </P>

    
    <P>There are several consensus PKC</A> phosphorylation sites in the SAF1
coding sequence. Some PKC</A> sites are present at the amino-terminal<SUP> </SUP>region, and one potential PKC</A> site is present within the fifth<SUP> </SUP>zinc
finger domain, located at the carboxyl-terminal region of<SUP> </SUP>SAF1 protein.
Although exact DNA-binding domains of SAF-1 are<SUP> </SUP>yet to be defined, it
can be speculated that PKC-induced phosphorylation<SUP> </SUP>at the fifth zinc
finger domain or at the other PKC</A> phosphorylation<SUP> </SUP>sites may induce some
conformational changes that facilitate the<SUP> </SUP>DNA binding ability of SAF1.
The importance of individual PKC</A><SUP> </SUP>phosphorylation sites, however,
remains to be determined via mutagenesis<SUP> </SUP>studies of all possible PKC</A>
phosphorylation sites. In conclusion,<SUP> </SUP>our study demonstrates that SAF1
protein, a member of the SAF/MAZ/Pur-1<SUP> </SUP>family of transcription factors,
becomes phosphorylated and activated<SUP> </SUP>by agonists of the PKC</A> signaling<SUP> </SUP>pathway.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We are grateful to Drs. Michael Blanar and
Erik Flemington for providing pAR(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">RI)59/60 and RSVGAL4DBD plus
GAL4-CAT plasmid<SUP> </SUP>DNAs.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was supported by National Institutes of Health
Grant DK49205 (to A.&nbsp;R. and B.&nbsp;K.&nbsp;R.) and CA56869 (to A.&nbsp;P.&nbsp;F.).The<SUP> </SUP>costs of publication of this
article were defrayed in part by<SUP> </SUP>the
payment of page charges. The article
must therefore be hereby<SUP> </SUP>marked
"<I>advertisement</I>" in
accordance with 18&nbsp;U.S.C. Section
1734<SUP>&nbsp;</SUP>solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN154"><SUP>&#182;</SUP></A>
To whom correspondence should be addressed: Dept. of
Veterinary Pathobiology, 124&nbsp;Connaway Hall, University of Missouri,
Columbia,<SUP> </SUP>MO 65211.&nbsp;Tel.: 573-882-4461; Fax: 573-884-5414; E-mail:
rayb@missouri.edu.

<P>


<P>
Published, JBC Papers in Press, September 19,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M007907200

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

SAA, serum amyloid
A;

SAF, SAA-activating factor;

PKC, protein kinase C;

CAT, chloramphenicol acetyltransferase;

EMSA, electrophoretic mobility shift
assay;

PMA, phorbol 12-myristate 13-acetate;

4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-PDD, 4<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-phorbol-12,13-didecanoate;

OAG, 1-oleoyl-2-acetyl-<I>sn</I>-glycerol;

DOG, 1,2-dioctanoyl-<I>sn</I>-glycerol;

RSV, Rous sarcoma virus;

IL, interleukin.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<BR CLEAR=ALL><TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Kushner, I.



(1982)

<I>Ann. N.&nbsp;Y.&nbsp;Acad. Sci.</I>
<B>389</B>,
39-48<!-- HIGHWIRE ID="275:50:39727:1" --><A HREF="/cgi/external_ref?access_num=7046585&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7046585&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Sipe, J. D.



(1994)

<I>Crit. Rev. Clin. Lab. Sci.</I>
<B>31</B>,
325-354<!-- HIGHWIRE ID="275:50:39727:2" --><A HREF="/cgi/external_ref?access_num=7888076&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7888076&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Strissel, K. J.,
Girard, M. T.,
West-Mays, J. A.,
Rinehart, W. B.,
Cook, J. R.,
Brinckerhoff, C. E.,
 and Fini, M. E.



(1997)

<I>Exp. Cell. Res.</I>
<B>237</B>,
275-287<!-- HIGHWIRE ID="275:50:39727:3" --><A HREF="/cgi/external_ref?access_num=10.1006/excr.1997.3783&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9434623&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9434623&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Brinckerhoff, C. E.,
Mitchell, T. I.,
Karmilowicz, M. J.,
Kluve-Beckerman, B.,
 and Benson, M. D.



(1989)

<I>Science</I>
<B>243</B>,
655-657<!-- HIGHWIRE ID="275:50:39727:4" --><A HREF="/cgi/external_ref?access_num=2536953&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2536953&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Mitchell, T. I.,
Coon, C. I.,
 and Brinckerhoff, C. E.



(1991)

<I>J. Clin. Invest.</I>
<B>87</B>,
1177-1185<!-- HIGHWIRE ID="275:50:39727:5" --><A HREF="/cgi/external_ref?access_num=1849144&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1849144&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Husebekk, A. B.,
Skogen, B.,
Husby, G.,
 and Marhaug, G.



(1985)

<I>Scand. J.&nbsp;Immunol.</I>
<B>21</B>,
283-287<!-- HIGHWIRE ID="275:50:39727:6" --><A HREF="/cgi/external_ref?access_num=3922050&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3922050&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Lowell, C A.,
Stearman, R. S.,
 and Morrow, J. F.



(1986)

<I>J. Biol. Chem.</I>
<B>261</B>,
8453-8461<!-- HIGHWIRE ID="275:50:39727:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=261/18/8453"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Mackiewicz, A.,
Ganapathi, M. K.,
Scultz, D.,
Samols, D.,
Reese, J.,
 and Kushner, I.



(1988)

<I>Biochem. J.</I>
<B>253</B>,
851-857<!-- HIGHWIRE ID="275:50:39727:8" --><A HREF="/cgi/external_ref?access_num=2460085&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2460085&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Urieli-Shoval, S.,
Meek, R. L.,
Hanson, R. H.,
Eriksen, N.,
 and Benditt, E. P.



(1994)

<I>Am. J.&nbsp;Pathol.</I>
<B>145</B>,
650-660<!-- HIGHWIRE ID="275:50:39727:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=amjpathol&resid=145/3/650">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Ganapathi, M. K.,
Rzewnicki, D.,
Samols, D.,
Jiang, S. L.,
 and Kushner, I.



(1991)

<I>J. Immunol.</I>
<B>147</B>,
1261-1265<!-- HIGHWIRE ID="275:50:39727:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jimmunol&resid=147/4/1261"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Ghezzi, P.,
 and Sipe, J. D.



(1988)

<I>Lymphokine Res.</I>
<B>7</B>,
157-166<!-- HIGHWIRE ID="275:50:39727:11" --><A HREF="/cgi/external_ref?access_num=3261378&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3261378&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Ray, A.,
 and Ray, B. K.



(1996)

<I>Mol. Cell. Biol.</I>
<B>16</B>,
1584-1594<!-- HIGHWIRE ID="275:50:39727:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=16/4/1584">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Ray, B. K.,
 and Ray, A.



(1997)

<I>Biochemistry</I>
<B>36</B>,
4662-4668<!-- HIGHWIRE ID="275:50:39727:13" --><A HREF="/cgi/external_ref?access_num=10.1021/bi9624595&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9109677&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9109677&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Ray, A.,
 and Ray, B. K.



(1998)

<I>Mol. Cell. Biol.</I>
<B>18</B>,
7327-7335<!-- HIGHWIRE ID="275:50:39727:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=18/12/7327"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Ray, B. K.,
Chatterjee, S.,
 and Ray, A.



(1999)

<I>DNA Cell Biol.</I>
<B>18</B>,
65-73<!-- HIGHWIRE ID="275:50:39727:15" --><A HREF="/cgi/external_ref?access_num=10.1089/104454999315637&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10025510&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10025510&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Ray, A.,
Schatten, H.,
 and Ray, B. K.



(1999)

<I>J. Biol. Chem.</I>
<B>274</B>,
4300-4308<!-- HIGHWIRE ID="275:50:39727:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=274/7/4300"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Newton, A. C.



(1995)

<I>J. Biol. Chem.</I>
<B>270</B>,
28495-28498<!-- HIGHWIRE ID="275:50:39727:17" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=jbc&resid=270/48/28495"><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Murray, N. R.,
Thompson, L. J.,
 and Fields, A. P.



(1997)

in 
<I>Protein Kinase C: Molecular Biology Intelligence Unit</I>


 (Parker, P. J.

, and Dekker, L., eds)
, pp. 97-120, R. G.&nbsp;Landis Co., Austin, TX
    <!-- HIGHWIRE ID="275:50:39727:18" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Liu, W. S.,
 and Hechman, C. A.



(1998)

<I>Calcium Signal.</I>
<B>10</B>,
529-542<!-- HIGHWIRE ID="275:50:39727:19" --><A HREF="/cgi/external_ref?access_num=10.1016/S0898-6568(98)00012-6&link_type=DOI">[CrossRef]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Kolomytkin, O. V.,
Marino, A. A.,
Sadasivan, K. K.,
Wolf, R. A.,
 and Albright, J. A.



(1999)

<I>Am. J.&nbsp;Physiol.</I>
<B>276</B>,
C9-C15<!-- HIGHWIRE ID="275:50:39727:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpcell&resid=276/1/C9"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Jarvis, W. D.,
Turner, A. J.,
Povrik, L. F.,
Traylor, R. S.,
 and Grant, S.



(1994)

<I>Cancer Res.</I>
<B>54</B>,
1704-1714<!-- HIGHWIRE ID="275:50:39727:21" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Gekeler, V.,
Boer, R.,
Uberall, F.,
Ise, W.,
Schubert, C.,
Utz, I.,
Hoffman, J.,
Sanders, K. H.,
Schachtele, C.,
Klemm, K.,
 and Grunicke, H.



(1996)

<I>Br. J.&nbsp;Cancer</I>
<B>74</B>,
897-905<!-- HIGHWIRE ID="275:50:39727:22" --><A HREF="/cgi/external_ref?access_num=8826855&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8826855&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Sambrook, J.,
Fritsch, E. F.,
 and Maniatis, T.



(1989)


<I>Molecular Cloning: A Laboratory Manual</I>

, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
    <!-- HIGHWIRE ID="275:50:39727:23" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Luckow, B.,
 and Schutz, G.



(1987)

<I>Nucleic Acids Res.</I>
<B>15</B>,
5490<!-- HIGHWIRE ID="275:50:39727:24" --><A HREF="/cgi/external_ref?access_num=3037497&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3037497&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Murray, N. R.,
Baumgardner, G. P.,
Burns, D. J.,
 and Fields, A. P.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
15847-15853<!-- HIGHWIRE ID="275:50:39727:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/21/15847"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Flemington, E. K.,
Speck, S. H.,
 and Kaelin, W. G., Jr.



(1993)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>90</B>,
6914-6918<!-- HIGHWIRE ID="275:50:39727:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=90/15/6914">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Blanar, M. A.,
 and Rutter, W. J.



(1992)

<I>Science</I>
<B>256</B>,
1014-1018<!-- HIGHWIRE ID="275:50:39727:27" --><A HREF="/cgi/external_ref?access_num=1589769&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1589769&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Bradford, M. M.



(1976)

<I>Anal. Biochem.</I>
<B>72</B>,
248-254<!-- HIGHWIRE ID="275:50:39727:28" --><A HREF="/cgi/external_ref?access_num=10.1006/abio.1976.9999&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=942051&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=942051&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Huberman, E.,
 and Jones, C. A.



(1985)

<I>Carcinog. Compr. Surv.</I>
<B>10</B>,
263-273<!-- HIGHWIRE ID="275:50:39727:29" --><A HREF="/cgi/external_ref?access_num=3933829&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3933829&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Vandenbark, G. R.,
 and Niedel, J. E.



(1984)

<I>J. Natl. Cancer Inst.</I>
<B>73</B>,
1013-1019<!-- HIGHWIRE ID="275:50:39727:30" --><A HREF="/cgi/external_ref?access_num=6387239&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6387239&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Mastro, A.M.



(1983)

<I>Cell Biol. Int. Rep.</I>
<B>7</B>,
881-893<!-- HIGHWIRE ID="275:50:39727:31" --><A HREF="/cgi/external_ref?access_num=6317204&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6317204&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Pelicci, P. G.,
Tabilio, A.,
Vainchenker, W.,
 and Testa, V.



(1983)

<I>Haematologica</I>
<B>68</B>,
411-426<!-- HIGHWIRE ID="275:50:39727:32" --><A HREF="/cgi/external_ref?access_num=6411535&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6411535&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Edbrooke, M. R.,
Burt, D. W.,
Cheshire, J. K.,
 and Woo, P.



(1989)

<I>Mol. Cell. Biol.</I>
<B>9</B>,
1908-1916<!-- HIGHWIRE ID="275:50:39727:33" --><A HREF="/cgi/external_ref?access_num=2747640&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2747640&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Sturm, R. A.,
Das, G.,
 and Herr, W.



(1988)

<I>Genes Dev.</I>
<B>2</B>,
1582-1599<!-- HIGHWIRE ID="275:50:39727:34" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=2/12/1582">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Bossone, S. A.,
Asselin, C.,
Patel, A. J.,
 and Marcu, K. B



(1992)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>89</B>,
7452-7456<!-- HIGHWIRE ID="275:50:39727:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=89/16/7452">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Kennedy, G. C.,
 and Rutter, W. J.



(1992)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>89</B>,
11498-11502<!-- HIGHWIRE ID="275:50:39727:36" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=89/23/11498">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Duncan, D. D.,
Stupakoff, A. J.,
Hedrick, S. M.,
Marcu, K. B.,
 and Siu, G.



(1995)

<I>Mol. cell. Biol.</I>
<B>15</B>,
3179-3186<!-- HIGHWIRE ID="275:50:39727:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=15/6/3179">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B38">38.</a>
    <TD VALIGN=TOP>

Parks, C. L.,
 and Shenk, T.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
4417-4430<!-- HIGHWIRE ID="275:50:39727:38" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/8/4417"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. K. Ray, R. Murphy, P. Ray, and A. Ray<BR>
	<STRONG>SAF-2, a Splice Variant of SAF-1, Acts as a Negative Regulator of Transcription</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;29,&nbsp;2002;
	277(48):
	46822 - 46830.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/48/46822">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/48/46822">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/48/46822">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://mcb.asm.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://mcb.asm.org"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Ray, G.-Y. Yu, and B. K. Ray<BR>
	<STRONG>Cytokine-Responsive Induction of SAF-1 Activity Is Mediated by a Mitogen-Activated Protein Kinase Signaling Pathway</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        February&nbsp;15,&nbsp;2002;
	22(4):
	1027 - 1035.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/22/4/1027">[Abstract]</A>

<A HREF="http://mcb.asm.org/cgi/content/full/22/4/1027">[Full Text]</A>
<A HREF="http://mcb.asm.org/cgi/reprint/22/4/1027">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	O. LaRochelle, V. Gagne, J. Charron, J.-W. Soh, and C. Seguin<BR>
	<STRONG>Phosphorylation Is Involved in the Activation of Metal-regulatory Transcription Factor 1 in Response to Metal Ions</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;9,&nbsp;2001;
	276(45):
	41879 - 41888.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/45/41879">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/45/41879">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/45/41879">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jimmunol.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jimmunol.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jimmunol.org"><IMG ALT="J Immunol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jimmunol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. K. Ray, J. Chen, and A. Ray<BR>
	<STRONG>Catalytic Subunit of Protein Kinase A Is an Interacting Partner of the Inflammation-Responsive Transcription Factor Serum Amyloid A-Activating Factor-1</STRONG><BR>
	
		
			J. Immunol.,
		
	
        
        August&nbsp;15,&nbsp;2001;
	167(4):
	2343 - 2348.
<BR>
<A HREF="http://www.jimmunol.org/cgi/content/abstract/167/4/2343">[Abstract]</A>

<A HREF="http://www.jimmunol.org/cgi/content/full/167/4/2343">[Full Text]</A>
<A HREF="http://www.jimmunol.org/cgi/reprint/167/4/2343">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/50/39727">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/50/39727">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/50/39727">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/50/39727&title=Activation+of+Transcription+Factor+SAF+Involves+Its+Phosphorylation+by+Protein+Kinase+C">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007907200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10995778&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10995778&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Ray+A&link_type=AUTHORSEARCH">Ray, A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Ray+BK&link_type=AUTHORSEARCH">Ray, B. K.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/50/39727&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39727"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/50/39727">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/50/39727<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007907200v1">M007907200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue50/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
